- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Innovent Biologics (Suzhou) Co. Ltd.
Total 795 results
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingDiffuse Large B-Cell Lymphoma
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Suspended
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Malignant Tumors LymphomasUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedHomozygous Familial HypercholesterolemiaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedCLDN18.2 Positive Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedAdvanced Cutaneous Squamous Cell CarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingIndolent Non-hodgkin LymphomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedA Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106)Gastric AdenocarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedCancer, Solid TumorChina
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingAdvanced Malignant TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingAdvanced Hepatocellular CarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedHealthy Male SubjectsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced/Metastatic Solid MalignanciesUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedEsophageal Squamous Cell CarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedHypercholesterolemiaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.UnknownNeovascular Age-related Macular DegenerationChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingUnresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingObesity | Type 2 DiabetesChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingThyroid Eye Disease, TEDChina
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingSolid TumorsAustralia
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingAdvanced Biliary Tract CancerChina